The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Amgen; Astellas Pharma; Bristol-Myers Squibb; Merck Sharp & Dohme; Pierre Fabre; SERVIER
Expert Testimony - Astellas Pharma
Travel, Accommodations, Expenses - AstraZeneca; Jazz Pharmaceuticals; Pierre Fabre
GOBLET platform study: Preliminary safety and tumor response results for the relapsed anal carcinoma cohort in patients treated with pelareorep and atezolizumab.
 
Dominik Modest
Honoraria - Amgen; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Cor2Ed; GlaxoSmithKline; Lilly; Merck; Merck Serono; Onkowissen; Pierre Fabre; Sanofi; Seagen; SERVIER; Taiho Pharmaceutical; Takeda
Consulting or Advisory Role - Amgen; Cor2Ed; GlaxoSmithKline; Lilly; Merck Serono; Onkowissen; Pierre Fabre; Regeneron; SERVIER; Takeda
Research Funding - Amgen (Inst); Servier (Inst)
Travel, Accommodations, Expenses - Amgen; Merck Serono; SERVIER
 
Eray Goekkurt
No Relationships to Disclose
 
Thomas Heineman
Employment - Oncolytics
Leadership - Oncolytics
Stock and Other Ownership Interests - Abbott Laboratories; Abbvie; Amgen; Bristol-Myers Squibb/Celgene; GlaxoSmithKline; Halozyme; Johnson & Johnson/Janssen; Merck; Oncolytics; Pfizer; Takeda
Patents, Royalties, Other Intellectual Property - Halozyme: PCT/US19/32537 Methods of selecting subjects for combination cancer therapy with a polymer-conjugated soluble PH20 Genocea: PCT/US 62/855,309; PCT/US 62/848,527 Methods of identifying and/or selecting antigens that improve, increase and/or s
Travel, Accommodations, Expenses - Oncolytics
 
Uwe Martens
Stock and Other Ownership Interests - Lilly; Novo Nordisk
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene; Guardant Health; MSD Oncology; Roche
Travel, Accommodations, Expenses - Ipsen; Janssen Oncology; Lilly; Pierre Fabre
 
Anke Reinacher-Schick
Honoraria - Amgen; AstraZeneca; Bristol-Myers Squibb; MCI Group; Merck Serono; MSD; Roche
Consulting or Advisory Role - Amgen; AstraZeneca; Aurikamed; Boehringer Ingelheim; Bristol-Myers Squibb; Daiichi Sankyo; Janssen-Cilag; Merck Serono; MSD; Pierre Fabre; Roche; Servier
Research Funding - AIO-Studien (Inst); Alexion Pharmaceuticals (Inst); Amgen (Inst); AstraZeneca (Inst); BioNTech (Inst); Celgene (Inst); ERYTECH Pharma (Inst); Ipsen (Inst); Lilly (Inst); Rafael Pharmaceuticals (Inst); Roche (Inst); Servier (Inst)
Travel, Accommodations, Expenses - Amgen; MSD; Pierre Fabre; Roche
 
Jack Chater
No Relationships to Disclose
 
Thomas Seufferlein
Honoraria - AstraZeneca; BMS GmbH & Co. KG; Falk Foundation; MSD Oncology; Pierre Fabre; SERVIER; Takeda
Consulting or Advisory Role - BioNTech SE; Boehringer Ingelheim; Cantargia AB; Mirati Therapeutics; Olympus Medical Systems; Pierre Fabre; Scandion Oncology; SERVIER
Research Funding - Lilly/ImClone (Inst)
Travel, Accommodations, Expenses - Takeda
 
Matt Coffey
Employment - Oncolytics
Leadership - Oncolytics
Stock and Other Ownership Interests - Oncolytics
Patents, Royalties, Other Intellectual Property - Oncolytics
 
Ruimei Li
Employment - Oncolytics
Leadership - Oncolytics
Stock and Other Ownership Interests - Immunitybio; Iovance Biotherapeutics; Pfizer; sana biotechnology
Honoraria - Oncolytics
Consulting or Advisory Role - NA
Speakers' Bureau - NA
Research Funding - NA
Patents, Royalties, Other Intellectual Property - NA
Expert Testimony - NA
Travel, Accommodations, Expenses - oncolytics
Other Relationship - NA
(OPTIONAL) Uncompensated Relationships - NA
 
Richard Trauger
No Relationships to Disclose
 
Dirk Arnold
Employment - Asklepios Kliniken
Honoraria - Amgen; AstraZeneca; Boston Scientific; Bristol-Myers Squibb; Eisai Europe; Gilead Sciences; GlaxoSmithKline; Ipsen; Janssen Oncology; Merck Serono; Merck Sharp and Dome; Pierre Fabre; Sanofi/Regeneron; Seagen; SERVIER; Sirtex Medical; Takeda; TERUMO; Viatris
Consulting or Advisory Role - AstraZeneca; Bayer; Bristol-Myers Squibb; Merck Serono; MSD Oncology
Research Funding - Oncolytics (Inst)
Travel, Accommodations, Expenses - Boston Scientific
(OPTIONAL) Uncompensated Relationships - Deputy Editor Clin Colorectal Cancer; ESMO; ESMO Open